"Battelle is pleased that our long-standing relationship with MEDRAD has yielded this breakthrough product," said Barbara Kunz, President, Battelle Health and Life Sciences Global Business. "Together, we have made a difference in patient safety and have improved the quality of care for patients undergoing imaging studies."
MEDRAD and Battelle will accept the award at a ceremony on June 4, 2008, at the Medical Design & Manufacturing (MD&M) East 2008 Conference and Exposition in New York City. Additionally, the MEDRAD XDS(TM) Extravasation Detector will appear with the other MDEA winners in the April 7 issue of Medical Device & Diagnostic Industry (MD&DI).
Battelle's Global Health and Life Sciences business delivers a comprehensive set of R&D services to solve complex challenges for government health agencies and medical device, biotechnology, and pharmaceutical firms. Including its national laboratories, Battelle oversees over $200 million annually in health and life sciences-research contributing to advances in medical devices, pharmaceuticals, public health, and next-generation diagnostics and therapeutics.
Battelle is the world's largest non-profit independent research and development organization, overseeing 20,000 employees in more than 130 locations worldwide, including five national laboratories Battelle manages or co-manages for the U.S. Department of Energy. Headquartered in Columbus, Ohio, Battelle conducts $4 billion in R&D annually through contract research, laboratory management, and technology commercialization. As a non-profit charitable trust with an eye toward the future, Battelle actively supports and promotes science and math education.
Copyright©2008 PR Newswire.
All rights reserved